http://www.thedividendguyblog.com/one-investor-sells-another-investor-buys/ One Guy's Journey to Passive Income Through Dividend Investing Sun, 14 Mar 2010 11:17:23 -0600 http://wordpress.org/?v=2.9.2 hourly 1 http://www.thedividendguyblog.com/one-investor-sells-another-investor-buys/comment-page-1/#comment-3222 empty spaces Mon, 30 Oct 2006 05:24:48 +0000 http://www.thedividendguyblog.com/2006/10/28/one-investor-sells-another-investor-buys/#comment-3222 well, since there's someone who bought every stock you sold, there are definitely people with the opposite view points! well, since there’s someone who bought every stock you sold, there are definitely people with the opposite view points!

]]> http://www.thedividendguyblog.com/one-investor-sells-another-investor-buys/comment-page-1/#comment-3218 George from FatPitchFinancials.com Sat, 28 Oct 2006 23:13:59 +0000 http://www.thedividendguyblog.com/2006/10/28/one-investor-sells-another-investor-buys/#comment-3218 I <a href="http://www.fatpitchfinancials.com/27/vioxx-gives-merck-some-pain/" rel="nofollow">bought Merck</a> back in October of 2004. The key to avoiding mistakes like the one you made with Merck is to evaluate a company's long term cash generating capability. Vioxx was a one time liability disaster, but one that is typical in the pharmaceutical sector. As long as a company like Merck can keep producing new important drugs under patent protection then its long term value will remain intact even if one of its drugs generates a huge liability. I bought Merck back in October of 2004. The key to avoiding mistakes like the one you made with Merck is to evaluate a company’s long term cash generating capability. Vioxx was a one time liability disaster, but one that is typical in the pharmaceutical sector. As long as a company like Merck can keep producing new important drugs under patent protection then its long term value will remain intact even if one of its drugs generates a huge liability.

]]>